10x Genomics Debt to Equity Ratio 2018-2024 | TXG
Current and historical debt to equity ratio values for 10x Genomics (TXG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. 10x Genomics debt/equity for the three months ending December 31, 2024 was 0.00.
| 10x Genomics Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.21B | $0.71B | 0.29 |
| 2024-09-30 | $0.22B | $0.72B | 0.30 |
| 2024-06-30 | $0.21B | $0.72B | 0.28 |
| 2024-03-31 | $0.20B | $0.72B | 0.28 |
| 2023-12-31 | $0.22B | $0.74B | 0.30 |
| 2023-09-30 | $0.20B | $0.75B | 0.27 |
| 2023-06-30 | $0.20B | $0.79B | 0.25 |
| 2023-03-31 | $0.21B | $0.80B | 0.26 |
| 2022-12-31 | $0.22B | $0.81B | 0.28 |
| 2022-09-30 | $0.22B | $0.78B | 0.28 |
| 2022-06-30 | $0.22B | $0.78B | 0.28 |
| 2022-03-31 | $0.20B | $0.81B | 0.24 |
| 2021-12-31 | $0.20B | $0.82B | 0.25 |
| 2021-09-30 | $0.19B | $0.80B | 0.24 |
| 2021-06-30 | $0.19B | $0.79B | 0.25 |
| 2021-03-31 | $0.20B | $0.75B | 0.27 |
| 2020-12-31 | $0.19B | $0.74B | 0.26 |
| 2020-09-30 | $0.22B | $0.83B | 0.26 |
| 2020-06-30 | $0.19B | $0.39B | 0.49 |
| 2020-03-31 | $0.20B | $0.41B | 0.49 |
| 2019-12-31 | $0.19B | $0.42B | 0.44 |
| 2019-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.10B | $0.02B | 4.35 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.918B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |